Carbidopa And Levodopa Capsule, Extended Release
Product Images NDC 70518-4610

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 70518-4610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (10c40374 C287 4608 Bd08 5bab623bbe1d 01)

FDA Label Image

Image (10c40374 C287 4608 Bd08 5bab623bbe1d 02)

FDA Label Image

Mm1 (Carbidopa Levodopa 61.25mg 245mg 70518 4610 00)

Mm1 (Carbidopa Levodopa 61.25mg 245mg 70518 4610 00)
This text provides information about a medication, Carbidopa-Levodopa, in capsule form. It includes details such as storage instructions, dosage information, manufacturer, and expiration date. The medication is produced by Mylan Pharmaceuticals and is repackaged by RemedyRepack. It is recommended to protect the medication from light and moisture, keep out of reach of children, and store at a temperature between 20-25°C.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This text contains information about a medication: Carbidopa/levodopa capsules manufactured by 2ydus Pharm. It includes a warning to protect the medication from light and moisture, details about dosage information, storage instructions, and contact information for the repackaging company, RemedyRepack.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.